The Current Status of Cell-Based Therapies for Primary Knee Osteoarthritis.

Clicks: 302
ID: 54982
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
There is a growing interest in cell therapy for knee osteoarthritis. This study systematically reviews the current status of cell-based therapies. The authors review treatment modalities, clinical outcomes, and the economics of cell therapy. Inclusion criteria were articles containing cellular therapy, platelet-rich plasma, and knee osteoarthritis in the title. Letters, editorial material, abstracts not published, and manuscripts with incomplete data were excluded. Forty-two articles met these inclusion criteria and were critically reviewed. Cell-based therapy holds promise as a means of restoring deficient local cartilage cell populations. There is no evidence-based information for the use of cell-based therapies in knee osteoarthritis.
Reference Key
vakharia2019thethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vakharia, Rushabh M;Roche, Martin W;Alcerro, Jose Carlos;Lavernia, Carlos Jesus;
Journal the orthopedic clinics of north america
Year 2019
DOI
S0030-5898(19)30089-6
URL
Keywords
cell therapy stem cells knee osteoarthritis conservative management prp platelet-rich plasma

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.